Vigil presents data on oral small molecule program including VG-3927
Vigil Neuroscience (VIGL) presented data highlighting its oral small molecule program, including its lead clinical candidate VG-3927, in two ...
Mount Sinai Launches AI Small Molecule Drug Discovery Center
The AI Small Molecule Drug Discovery Center will focus on three core areas: designing novel drug-like molecules using generative AI, optimizing existing compounds to enhance their efficacy and safety, ...